Do we have to stop anticoagulant and platelet-inhibitor treatments during proctological surgery?

Colorectal Disease

Volumn 14, Issue 12, 2012, Pages 1516-1520

  Pigot, F ^a   Juguet, F ^b   Bouchard, D ^a   Castinel, A ^b  

^a Hopital Bagatelle   (France)

^b Clinique Théodore Ducos   (France)

Author keywords

Acetylsalicylic acid; Anticoagulants; Clopidogrel; Haemorrhage; Haemorrhoids; Surgery

Indexed keywords

CLOPIDOGREL; HEPARIN;

ANTICOAGULANT THERAPY; ARTICLE; CLINICAL DECISION MAKING; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; HEMORRHOID; HEMORRHOIDECTOMY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM SURGERY; RISK ASSESSMENT;

ADULT; ANTICOAGULANTS; ASPIRIN; BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; FEMALE; HEMORRHOIDS; HEPARIN; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT READMISSION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; TICLOPIDINE;

EID: 84869217120     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2012.03063.x     Document Type: Article

References (9)

1. Burch J, Epstein D, Baba-Akbari A et al. Stapled haemorrhoidectomy (haemorrhoidopexy) for the treatment of haemorrhoids: a systematic review and economic evaluation. Health Technol Assess 2008; 12: 1-193.
2. Chen HH, Wang JY, Changchien CR et al. Risk factors associated with posthemorrhoidectomy secondary hemorrhage: a single-institution prospective study of 4, 880 consecutive closed hemorrhoidectomies. Dis Colon Rectum 2002; 45: 1096-9.
3. Pigot F, Juguet F, Bouchard D, Castinel A, Vove JP. Prospective survey of secondary bleeding following anorectal surgery in a consecutive series of 1, 269 patients. Clin Res Hepatol Gastroenterol 2011; 35: 41-7.
4. Professional recommendation edited by the Haute Autorité de Santé, April 2008: http://www.has-sante.fr/portail/upload/docs/application/pdf/2008-09/surdosage_en_avk_situations_a_risque_et_accidents_hemorragiques_-_synthese_des_recommandations_v2.pdf; accessed 16 June 2012.
5. Cohen M. Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care. Mayo Clin Proc 2009; 84: 149-60.
6. Collet JP, Montalescot G, Blanchet B et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004; 110: 2361-7.
7. Lordkipanidzé M, Diodati JG, Pharand C. Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence. Pharmacol Ther 2009; 123: 178-86.
8. Biondi-Zoccai GG, Lotrionte M, Agostoni P et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50, 279 patients at risk for coronary artery disease. Eur Heart J 2006; 27: 2667-74.
9. Nelson RS, Ewing BM, Ternent C, Shashidharan M, Blatchford GJ, Thorson AG. Risk of late bleeding following hemorrhoidal banding in patients on antithrombotic prophylaxis. Am J Surg 2008; 196: 994-9.